Quarterly report [Sections 13 or 15(d)]

Consolidated Condensed Statements of Operations

v3.26.3
Consolidated Condensed Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 03, 2026
Sep. 27, 2025
Oct. 03, 2026
Sep. 27, 2025
Income Statement [Abstract]        
Sales $ 271,679 $ 211,447 $ 762,255 $ 622,061
Cost of Products Sold 177,705 146,936 506,251 443,874
Gross Profit 93,974 64,511 256,004 178,187
Research and Development Expenses 9,272 10,210 32,230 32,849
Selling, General and Administrative Expenses 30,719 31,246 102,094 104,388
Income from Operations 53,983 23,055 121,680 40,950
Loss on Settlement of Debt 0 32,644 0 32,644
Other Expense (Income), Net 190 (185) 580 (562)
Interest Expense, Net of Interest Income 1,838 2,920 6,506 9,167
Income (Loss) Before Income Taxes 51,955 (12,324) 114,594 (299)
Provision for (Benefit from) Income Taxes (249) (1,226) 1,790 (43)
Net Income (Loss) $ 52,204 $ (11,098) $ 112,804 $ (256)
Earnings (Loss) Per Share:        
Basic (in usd per share) [1] $ 1.21 $ (0.26) $ 2.63 $ (0.01)
Diluted (in usd per share) [1] $ 1.08 $ (0.26) $ 2.36 $ (0.01)
[1] All per share information have been adjusted to reflect the impact of the twenty percent Class B stock distribution to shareholders of record on June 15, 2026.